back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-07-05 10:19 Tx date 2024-06-30 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$39,351
+11,540 vol $3.41 each |
132,440 | |
| Filed 2024-04-01 14:05 Tx date 2024-03-31 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$38,957
+10,252 vol $3.80 each |
120,900 | |
| Filed 2024-03-25 13:46 Tx date 2024-03-25 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$203,114
+49,783 vol $4.08 each |
110,648 | |
| Filed 2024-01-04 16:05 Tx date 2023-12-31 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$21,793
+5,720 vol $3.81 each |
60,865 | |
| Filed 2023-10-05 15:04 Tx date 2023-09-30 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$21,816
+4,261 vol $5.12 each |
55,145 | |
| Filed 2023-07-05 15:36 Tx date 2023-06-30 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$33,385
+5,786 vol $5.77 each |
50,884 | |
| Filed 2023-04-04 16:25 Tx date 2023-03-31 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$19,517
+3,184 vol $6.13 each |
45,098 | |
| Filed 2023-01-04 15:25 Tx date 2022-12-31 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$18,756
+1,962 vol $9.56 each |
41,914 | |
| Filed 2023-01-03 09:03 Tx date 2022-09-30 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$18,351
+2,062 vol $8.90 each |
19,770 | |
| Filed 2022-10-05 16:03 Tx date 2022-09-02 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$18,351
+2,062 vol $8.90 each |
||
| Filed 2022-12-16 15:59 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$204,040
+20,182 vol $10.11 each |
39,952 | |
| Filed 2022-10-05 16:03 Tx date 2022-09-02 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$18,351
+2,062 vol $8.90 each |
19,770 | |
| Filed 2022-07-05 15:12 Tx date 2022-06-30 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$18,200
+1,456 vol $12.50 each |
17,708 | |
| Filed 2022-04-04 09:59 Tx date 2022-03-31 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$18,116
+1,211 vol $14.96 each |
16,252 | |
| Filed 2022-01-10 16:42 Tx date 2021-12-31 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$18,104
+1,199 vol $15.10 each |
15,041 | |
| Filed 2021-12-13 16:56 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$191,520
+12,871 vol $14.88 each |
13,842 | |
| Filed 2021-12-13 16:55 Tx date 2021-09-30 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$17,652
+971 vol $18.18 each |
971 | |
| Filed 2021-12-13 16:54 Tx date 2019-03-21 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-11-13 12:29 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$155,600
+10,000 vol $15.56 each |
21,695 | |
| Filed 2019-06-11 10:41 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$181,857
+11,695 vol $15.55 each |
11,695 | |
| Filed 2019-06-11 10:40 Tx date 2019-03-21 |
$HLS
HLS Therapeutics Inc. |
Brege, Laura Ann
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|